HTL0039732
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for HTL0039732, covering 2025-06-08 to 2025-06-08. Get the full timeline:
Most recent: Clinical Trial Update: HTL0039732 in Participants With Advanced Solid Tumours [Phase 1, Phase 2]